Senior insider sale
Chief Executive Officer at BEONE MEDICINES LTD. — senior position signals high conviction
$3.75M
13.99K shares
What this filing means
OYLER JOHN plans to sell 13.99K shares of BEONE MEDICINES LTD. valued at approximately $3.75M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/23/2026ACC: 0001950047-26-006411
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
13.99K
Shares to sell
$3.75M
Approx. market value
3.41K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Not Applicable
6/22/2026
3.41KTotal acquired3.41K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/22/2026 | Restricted Stock Vesting Under a Registered Plan Not Applicable | 3.41K | — |
| Total | 3.41K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
3.69K
Market value
$980.7K
6/16/2026
—Completed
Units to sell
1.95K
Market value
$501.4K
6/11/2026
—Completed
Units to sell
4.94K
Market value
$1.34M
6/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.41K
Market value
$933.6K
6/23/2026
Total
Units
13.99K
Value
$3.75M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/16/2026 | 3.69K | $980.7K | — | Completed |
6/11/2026 | 1.95K | $501.4K | — | Completed |
6/8/2026 | 4.94K | $1.34M | — | Completed |
| Planned — Approximate Date | ||||
6/23/2026 | 3.41K | $933.6K | NASDAQ | Planned |
| Total | 13.99K | $3.75M | ||